Tatsuya Ozawa1, Syuzo Kaneko2, Frank Szulzewsky3, Zhiwei Qiao4, Mutsumi Takadera5,6, Yoshitaka Narita7, Tadashi Kondo4, Eric C Holland3,8, Ryuji Hamamoto9,10, Koichi Ichimura11. 1. Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan. taozawa@ncc.go.jp. 2. Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan. sykaneko@ncc.go.jp. 3. Human Biology Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Mailstop C3-168, Seattle, WA, 98109, USA. 4. Division of Rare Cancer Research, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan. 5. Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan. 6. Department of Neurosurgery, Yokohama City University, Yokohama, Kanagawa, 236-0027, Japan. 7. Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan. 8. Seattle Tumor Translational Research Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA, 98109, USA. 9. Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan. 10. RIKEN Center for Advanced Intelligence Project, Cancer Translational Research Team, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan. 11. Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan. kichimur@ncc.go.jp.
Correction to: Ozawa et al. acta neuropathol commun (2021) 9:36 https://doi.org/10.1186/s40478-021-01135-4
In the original publication of the article [1] there were errors introduced during the publication process involving the italic emphasis. These errors are as followed:The italicized terms of “RELA” have been amended as this was erroneously applied to the genes and proteins.